AstraZeneca - Immuno-oncology treatment paradigms for first-line ES SCLC and unresectable stage III NSCLC Industry Satellite Symposium

The evolving role of immuno-oncology treatment for ES-SCLC

Lecture Time
17:00 - 17:15
Speakers
  • E. Arriola (Barcelona, Spain)
Session Name
AstraZeneca - Immuno-oncology treatment paradigms for first-line ES SCLC and unresectable stage III NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
16:10 - 17:40
Authors
  • E. Arriola (Barcelona, Spain)